Diabetic Retinopathy Market Report 2026
Download Free Sample Buy Now
Diabetic Retinopathy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Diabetic Retinopathy Market Report 2026

Global Outlook – By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Treatment (Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery), By End-User (Hospitals, Ambulatory Surgical Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Diabetic Retinopathy Market Overview

• Diabetic Retinopathy market size has reached to $9.26 billion in 2025

• Expected to grow to $13.54 billion in 2030 at a compound annual growth rate (CAGR) of 8%

• Growth Driver: Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World

• Market Trend: AI Partnerships Transforming Diabetic Retinopathy Screening

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Diabetic Retinopathy Market?

Diabetic retinopathy is a complication of diabetes that affects the retina, the light-sensitive tissue at the back of the eye, resulting from damage to blood vessels caused by prolonged high blood sugar levels; this condition can lead to vision loss and even blindness if not properly managed, making regular eye examinations essential for early detection and treatment.

The main diabetic retinopathy types are proliferative diabetic retinopathy, and non-proliferative diabetic retinopathy. Proliferative diabetic retinopathy refers to the advanced stage in which aberrant new blood vessels develop on the retina's surface. The various treatment methods are anti-vegf drugs, intraocular steroid injection, laser photocoagulation, and vitreoretinal surgery used in hospitals, ambulatory surgical centers, and others.

Diabetic Retinopathy Market Global Report 2026 Market Report bar graph

What Is The Diabetic Retinopathy Market Size and Share 2026?

The diabetic retinopathy market size has grown strongly in recent years. It will grow from $9.26 billion in 2025 to $9.97 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing diabetes prevalence, late diagnosis of retinal damage, limited screening access, rising vision impairment cases, dependence on hospital-based eye care.

What Is The Diabetic Retinopathy Market Growth Forecast?

The diabetic retinopathy market size is expected to see strong growth in the next few years. It will grow to $13.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growth of ai-assisted screening tools, expansion of ophthalmology clinics, increasing anti-vegf therapy adoption, focus on preventive eye care, rising aging diabetic population. Major trends in the forecast period include rising adoption of retinal screening programs, increased use of anti-vegf therapies, expansion of early detection and monitoring, growing integration of AI-based retinal imaging, rising focus on vision preservation.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Diabetic Retinopathy Market Segmentation

1) By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy

2) By Treatment: Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment

2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR, Moderate NPDR, Severe NPDR

What Is The Driver Of The Diabetic Retinopathy Market?

The rising prevalence of diabetes is expected to propel the growth of the diabetic retinopathy market going forward. Diabetes refers to a long-term metabolic disease that causes high blood glucose levels. The rise in the prevalence of diabetes is mainly driven by overweight, obesity, genetics, and physical inactivity, whereas patients with diabetes have too much sugar in their blood, which can damage the retina, which is part of the eye that detects light and sends signals to your brain through a nerve in the back of eye. For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, it rose by 21%. The proportion of people meeting target HbA1c levels also reached 37.9%, the highest ever recorded by the National Diabetes Audit. Therefore, the rising prevalence of diabetes is driving the growth of the diabetic retinopathy industry.

Key Players In The Global Diabetic Retinopathy Market

Major companies operating in the diabetic retinopathy market are Pfizer Inc., F-Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc., Genentech Inc., Santen Pharmaceutical Co Ltd., Carl Zeiss Meditec AG, Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co Ltd., IRIDEX Corporation, Alimera Science Inc., Oxurion NV, EyePoint Pharmaceuticals, Opthea Limited, KalVista Pharmaceuticals Inc., Regenxbio Inc., Kodiak Sciences Inc., Oculis, Verseon International Corporation, Clearside Biomedical Inc.

Global Diabetic Retinopathy Market Trends and Insights

Major companies operating in the diabetic retinopathy market are focused on partnerships to increase their profitability in the market. Partnerships in diabetic retinopathy refer to collaborative efforts between various stakeholders, such as healthcare providers, researchers, pharmaceutical companies, and advocacy groups, to address the challenges associated with diabetic retinopathy. For instance, in October 2023, AEYE Health, a US-based provider of AI-based diagnostics for retinal imaging collaborated with Topcon Screen, a Japan-based diabetic screening platform. The goal of their collaboration is to provide point-of-care screening for diabetic retinopathy using artificial intelligence, ensuring swift and precise results, so that primary care clinicians can directly conduct diabetic retinopathy screenings in their clinics. This approach aims to reduce the chances of non-compliance and address care gaps associated with diabetic retinopathy screening by offering immediate, accurate assessments at the point of care.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Diabetic Retinopathy Market?

In January 2025, Regeneron Pharmaceuticals Inc, a US–based biotechnology company, acquired Oxular Limited for an undisclosed amount. With this acquisition, Regeneron gains access to Oxular’s proprietary sustained-release Oxuspheres technology and its Oxulumis suprachoroidal microcatheter delivery system, thereby enhancing its retinal drug-delivery capabilities while improving its operational scale and therapeutic reach in ophthalmic care. Oxular Limited is a UK–based biotechnology company focused on developing long-acting drug formulations and targeted delivery solutions for retinal diseases, known for its lead candidate OXU-001 and its integrated drug-device platform for posterior-segment disorders.

Regional Outlook

North America was the largest region in the diabetic retinopathy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetic Retinopathy Market?

The diabetic retinopathy market includes revenues earned by entities by providing ophthalmologic examination, eye management and retinal imaging and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetic Retinopathy Market Report 2026?

The diabetic retinopathy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic retinopathy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Diabetic Retinopathy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $9.97 billion
Revenue Forecast In 2035 $13.54 billion
Growth Rate CAGR of 7.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Treatment, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F-Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc., Genentech Inc., Santen Pharmaceutical Co Ltd., Carl Zeiss Meditec AG, Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co Ltd., IRIDEX Corporation, Alimera Science Inc., Oxurion NV, EyePoint Pharmaceuticals, Opthea Limited, KalVista Pharmaceuticals Inc., Regenxbio Inc., Kodiak Sciences Inc., Oculis, Verseon International Corporation, Clearside Biomedical Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Diabetic Retinopathy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Diabetic Retinopathy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Diabetic Retinopathy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Diabetic Retinopathy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Retinal Screening Programs

4.2.2 Increased Use Of Anti-Vegf Therapies

4.2.3 Expansion Of Early Detection And Monitoring

4.2.4 Growing Integration Of Ai-Based Retinal Imaging

4.2.5 Rising Focus On Vision Preservation

5. Diabetic Retinopathy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmology Clinics

5.3 Specialty Eye Care Centers

5.4 Ambulatory Surgical Centers

5.5 Diagnostic Imaging Centers

6. Diabetic Retinopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Diabetic Retinopathy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Diabetic Retinopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Diabetic Retinopathy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Diabetic Retinopathy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Diabetic Retinopathy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Diabetic Retinopathy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Diabetic Retinopathy Market Segmentation

9.1. Global Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy

9.2. Global Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery

9.3. Global Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ambulatory Surgical Centers, Other End Users

9.4. Global Diabetic Retinopathy Market, Sub-Segmentation Of Proliferative Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment

9.5. Global Diabetic Retinopathy Market, Sub-Segmentation Of Non-Proliferative Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mild NPDR, Moderate NPDR, Severe NPDR

10. Diabetic Retinopathy Market Regional And Country Analysis

10.1. Global Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Diabetic Retinopathy Market

11.1. Asia-Pacific Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Diabetic Retinopathy Market

12.1. China Diabetic Retinopathy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Diabetic Retinopathy Market

13.1. India Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Diabetic Retinopathy Market

14.1. Japan Diabetic Retinopathy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Diabetic Retinopathy Market

15.1. Australia Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Diabetic Retinopathy Market

16.1. Indonesia Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Diabetic Retinopathy Market

17.1. South Korea Diabetic Retinopathy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Diabetic Retinopathy Market

18.1. Taiwan Diabetic Retinopathy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Diabetic Retinopathy Market

19.1. South East Asia Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Diabetic Retinopathy Market

20.1. Western Europe Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Diabetic Retinopathy Market

21.1. UK Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Diabetic Retinopathy Market

22.1. Germany Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Diabetic Retinopathy Market

23.1. France Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Diabetic Retinopathy Market

24.1. Italy Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Diabetic Retinopathy Market

25.1. Spain Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Diabetic Retinopathy Market

26.1. Eastern Europe Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Diabetic Retinopathy Market

27.1. Russia Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Diabetic Retinopathy Market

28.1. North America Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Diabetic Retinopathy Market

29.1. USA Diabetic Retinopathy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Diabetic Retinopathy Market

30.1. Canada Diabetic Retinopathy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Diabetic Retinopathy Market

31.1. South America Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Diabetic Retinopathy Market

32.1. Brazil Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Diabetic Retinopathy Market

33.1. Middle East Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Diabetic Retinopathy Market

34.1. Africa Diabetic Retinopathy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Diabetic Retinopathy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Diabetic Retinopathy Market Regulatory and Investment Landscape

36. Diabetic Retinopathy Market Competitive Landscape And Company Profiles

36.1. Diabetic Retinopathy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Diabetic Retinopathy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Diabetic Retinopathy Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F-Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Diabetic Retinopathy Market Other Major And Innovative Companies

Allergan plc., Genentech Inc., Santen Pharmaceutical Co Ltd., Carl Zeiss Meditec AG, Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co Ltd., IRIDEX Corporation, Alimera Science Inc., Oxurion NV, EyePoint Pharmaceuticals, Opthea Limited, KalVista Pharmaceuticals Inc., Regenxbio Inc.

38. Global Diabetic Retinopathy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Diabetic Retinopathy Market

40. Diabetic Retinopathy Market High Potential Countries, Segments and Strategies

40.1 Diabetic Retinopathy Market In 2030 - Countries Offering Most New Opportunities

40.2 Diabetic Retinopathy Market In 2030 - Segments Offering Most New Opportunities

40.3 Diabetic Retinopathy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Diabetic Retinopathy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Diabetic Retinopathy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Diabetic Retinopathy Market, Supply Chain Analysis
  • Table 4: Global Diabetic Retinopathy Market, Major Raw Material Providers
  • Table 5: Global Diabetic Retinopathy Market, Major Resource Providers
  • Table 6: Global Diabetic Retinopathy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Diabetic Retinopathy Market, Major Distributors And Channel Partners
  • Table 8: Global Diabetic Retinopathy Market, Key Technologies & Future Trends
  • Table 9: Global Diabetic Retinopathy Market, Major Trends
  • Table 10: Global Diabetic Retinopathy Market, Major End Users
  • Table 11: Global Diabetic Retinopathy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Diabetic Retinopathy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Diabetic Retinopathy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Diabetic Retinopathy Market - TAM, US$ Billion, 2025
  • Table 15: Global Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Diabetic Retinopathy Market, Sub-Segmentation Of Proliferative Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Diabetic Retinopathy Market, Sub-Segmentation Of Non-Proliferative Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Diabetic Retinopathy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Diabetic Retinopathy Market - Company Scoring Matrix
  • Table 96: Pfizer Inc. Financial Performance
  • Table 97: F-Hoffmann-La Roche Ltd. Financial Performance
  • Table 98: Bayer AG Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 101: Global Diabetic Retinopathy Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Diabetic Retinopathy Market, Competitive Dashboard
  • Table 103: Global Diabetic Retinopathy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Diabetic Retinopathy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Diabetic Retinopathy Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 106: Global, Diabetic Retinopathy Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Diabetic Retinopathy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Diabetic Retinopathy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Diabetic Retinopathy Market, Supply Chain Analysis
  • Figure 4: Global Diabetic Retinopathy Market, Major Raw Material Providers
  • Figure 5: Global Diabetic Retinopathy Market, Major Resource Providers
  • Figure 6: Global Diabetic Retinopathy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Diabetic Retinopathy Market, Major Distributors And Channel Partners
  • Figure 8: Global Diabetic Retinopathy Market, Key Technologies & Future Trends
  • Figure 9: Global Diabetic Retinopathy Market, Major Trends
  • Figure 10: Global Diabetic Retinopathy Market, Major End Users
  • Figure 11: Global Diabetic Retinopathy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Diabetic Retinopathy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Diabetic Retinopathy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Diabetic Retinopathy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Diabetic Retinopathy Market, Sub-Segmentation Of Proliferative Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Diabetic Retinopathy Market, Sub-Segmentation Of Non-Proliferative Diabetic Retinopathy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Diabetic Retinopathy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Diabetic Retinopathy Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc. Financial Performance
  • Figure 97: F-Hoffmann-La Roche Ltd. Financial Performance
  • Figure 98: Bayer AG Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 101: Global Diabetic Retinopathy Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Diabetic Retinopathy Market, Competitive Dashboard
  • Figure 103: Global Diabetic Retinopathy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Diabetic Retinopathy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Diabetic Retinopathy Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 106: Global, Diabetic Retinopathy Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Printed Circuit Board Market 2025 – By Type (Single Sided, Double Sided, Multi-Layer, High Density Interconnect (HDI), Other Types), By Substrate (Rigid, Flexible, Rigid-Flex), By Laminate Type (FR-4, Polyimide, Other La...

Ketolides Market Report 2026 - Global Outlook – By Drug Type (Telithromycin, Cethromycin, Solithromycin), By Indication (Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis), By Microorganism (Streptococcus Pneu...

Thermostatic Faucet Market Report 2026 - Global Outlook – By Product (Single Lever, Two Handle), By Distribution Channel (Online, Offline), By End User (Commercial, Residential) – Market Size, Trends, Strategies, and For...

Unit Dose Manufacturing Market Report 2026 - Global Outlook – By Product (Liquid Unit Dose, Solid Unit Dose, Other Products), By Sourcing (In-House, Outsourcing), By End-User (Independent Pharmacies, Long Term Care Facil...

Rice Polisher Market Report 2026 - Global Outlook – By Type (Vertical Rice Polishers, Horizontal Rice Polishers, Other Rice Polishers), By Capacity (1 - 10 Ton, 10 - 20 Ton, More than 20 Ton), By End-User (Rice Mills, Fo...

Pharmacy Automation Solution Market Report 2026 - Global Outlook – By Type (Automated Medication Dispensing, Automated Packaging And Labeling, Automated Storage And Retrieval, Automated Medication Compounding, Other Type...

Clinical Data Analytics Solutions Market Report 2026 - Global Outlook – By Solution (Platform, Services), By Deployment (On-Premise, Cloud-Based), By Application (Clinical Decision Support, Precision Health, Quality Impr...

Stationary Fuel Cell Market Report 2026 - Global Outlook – By Type ( Proton Exchange Membrane Fuel Cell (PEMFC), Phosphoric Acid Fuel Cell (PAFC), Molten Carbonate Fuel Cell (MCFC), Solid Oxide Fuel Cell (SOFC), Direct M...

Frequently Asked Questions

The Diabetic Retinopathy market was valued at $9.26 billion in 2025, increased to $9.97 billion in 2026, and is projected to reach $13.54 billion by 2030.

The global Diabetic Retinopathy market is expected to grow at a CAGR of 8.0% from 2026 to 2035 to reach $13.54 billion by 2035.

Some Key Players in the Diabetic Retinopathy market Include, Pfizer Inc., F‑Hoffmann‑La Roche Ltd., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc., Genentech Inc., Santen Pharmaceutical Co Ltd., Carl Zeiss Meditec AG, Lumenis Ltd

Major trend in this market includes: AI Partnerships Transforming Diabetic Retinopathy Screening. For further insights on this market. request a sample here

North America was the largest region in the diabetic retinopathy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us